PC
MXCT icon

Pier Capital’s MaxCyte MXCT Stock Holding History

Pier Capital’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,074,164
Closed -$5.86M – 119
2022
Q4 		$5.86M Sell
1,074,164
-188,490
-15% -$1.16M 0.96% 54
2022
Q3 		$8.21M Sell
1,262,654
-102,769
-8% -$573K 1.41% 19
2022
Q2 		$6.46M Buy
1,365,423
+347,670
+34% +$1.71M 1.1% 49
2022
Q1 		$7.11M Sell
1,017,753
-6,498
-0.6% -$44.4K 0.91% 63
2021
Q4 		$10.4M Buy
1,024,251
+535,578
+110% +$5.75M 1.1% 46
2021
Q3 		$5.97M Buy
+488,673
New +$7.37M 0.62% 86

Other funds holding MXCT

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Pier Capital's MXCT Position: Q1 2023 in Review

Pier Capital sold out of MaxCyte (MXCT) in Q1 2023, closing a stake of 1,074,164 shares — an estimated $5.86M sold.

Pier Capital first reported a position in MXCT in Q3 2021 and held it in 6 quarters. The position peaked at $10.4M in Q4 2021. 114 funds tracked by Wall St. Rank hold MXCT as of Q1 2023.

  • Pier Capital reported no remaining MaxCyte position as of Q1 2023 after selling out during the quarter.
  • Pier Capital sold 1,074,164 MaxCyte shares in Q1 2023, an estimated $5.86M.
  • Pier Capital first reported a position in MaxCyte in Q3 2021 and held it in 6 quarters.
  • Pier Capital's MaxCyte position peaked at $10.4M in Q4 2021.
  • 114 funds tracked by Wall St. Rank held MaxCyte as of Q1 2023.

Based on Pier Capital's 13F filing for Q1 2023, filed 10 May 2023.